Neuro-Oncology_USZ
@NeuroOnco_USZ
Followers
121
Following
51
Media
14
Statuses
63
Group of medical doctors and scientists dedicated to preclinical and clinical research for brain tumor patients @Unispital_USZ
Zurich, Switzerland
Joined July 2022
In einer Studie der @ETH Zürich und des USZ erwies sich ein bekanntes Antidepressivum als vielversprechende Lösung zur Behandlung aggressiver #Hirntumoren. #Glioblastom
https://t.co/44NklAGrWV
usz.ch
Viele Krebsmedikamente scheitern bei der Behandlung von Gehirntumoren an der Blut-Hirn-Schranke – die Wirkstoffe gelangen erst gar nicht zum Tumor. In einer Studie der ETH Zürich und des Universitä...
1
5
17
We are beyond proud of our newest @NatureMedicine paper! Using pharmacoscopy & in-silico drug MoA discovery, we show that the antidepressant Vortioxietine is effective in #Glioblastoma primary patient material and in mouse models. https://t.co/MehHhQQOvR #PersonalizedMedicine
nature.com
Nature Medicine - A single-cell ex vivo screening of repurposable drugs in glioblastoma and machine learning of drug–target networks show that anti-tumor neuroactive drugs converge on the...
3
8
27
Last week I finally defended my PhD about CAR T cells against #glioblastoma. I am very grateful for everything I’ve learned during this time and for the continuous support of my PhD committee members and lab colleagues @usz_neurooncology. Excited for new challenges ahead!
5
3
44
The SOLA-Stafette 2024 is coming closer. For the second time in a row, our lab is running with #SOLAgegenKrebs to support cancer research. Feel free to help us supporting the @CCCZ_USZ below. Looking forward to a fantastic race!
Our young researchers need your support! And they are running for it at #SOLAgegenKrebs
https://t.co/kNULVBauNC
0
0
1
Last week we had a wonderful time at our annual lab retreat with stimulating discussions! 🇨🇭
1
2
7
1
18
57
📊 Patrick Roth presented today at #SNO2023 in Vancouver, Canada, the updated results and molecular subgroup analyses from the EORTC-1709-BTG #MIRAGEtrial on #glioblastoma within the session "#ClinicalTrials - Non-Immunologic". More: https://t.co/DaeLMVKvlQ
@NeuroOnc
0
3
6
We are having a great time at #SNO2023 @NeuroOnc and are grateful for the opportunity to present some of our ongoing research by posters and presentations. @to123w @AlidaSun7 @max5tall
0
4
14
Congratulations to our newly graduated PhDs Gioele Medici, Remi Weber and Thomas Look and all the best for your future! Fantastic work also from the supervisors Marian Neidert, Flavio Vasella and Tobias Weiss!
0
0
9
Congrats Jiawei!
#EANO2023 Congrats to Jiawei Chen for beeing awarded with the Young Investigator Travel Scholarship! We look forward to meeting young scientists and physicians in #NeuroOncology. Registration is still open: https://t.co/By6VxD2znl
#btsm @JChen930612 @OncoAlert @theIBTA
0
1
3
Not to forget our dear Jiawei Chen (@JChen930612) giving a fascinating talk about his research with adaptor CAR T cells targeting SSTR2 in meningiomas on friday.
0
0
2
We will be present at #EANO2023 and are happy to communicate recent findings. Come and join our talks and poster presentations.
1
1
5
Congrats Max!
#EANO2023 Congrats to Maximillian Mastall for being awarded with the Young Investigator Travel Scholarship! We look forward to meeting young scientists and physicians in #NeuroOncology. Registration is still open https://t.co/By6VxD2znl
#btsm @max5tall @OncoAlert @theIBTA
0
0
4
Still 3 days to #EANO2023, taking place Sept 21-24 in Rotterdam. Kick off with our Educational Day on Sept 21. Spend a day with peers while being inspired and gaining lots of new insightful knowledge! https://t.co/D3OshULpB2
#NeuroOncology #Neurosurgery #cancernurse #AHP #btsm
0
11
33
An explanation why Siglec-9 is an attractive therapeutic target in patients with #glioblastoma. Proud that our @AliciaBuck_ & @to123w could contribute.
Fighting brain cancer Researchers led by Professor Gregor Hutter from the @DepBiomedicine at the @UniBasel_en and @UniSpitalBasel publish their findings, which may pave the way for effective immunotherapies for glioblastomas in @ScienceMagazine
#research #publication
0
0
2
July 19 is #GlioblastomaAwarenessDay. Let's shine a light on #glioblastoma, the most common primary #braintumour of adults. We continue to fight for better treatments & a better quality of life for those living with this devastating disease. #GBMDay #btsm @OncoAlert @NBTStweets
0
50
83
Check out the new publicly available HLA class I and II antigen atlas for #meningioma including functional characterization. Congratulations to @MediciGioele and @MarianNeidert! And the amazing teams from @LabWalz @QBIC_tue @DKFZ @DKTK_. https://t.co/46lmrZCxAT
link.springer.com
Acta Neuropathologica - Meningiomas are the most common primary intracranial tumors. Although most symptomatic cases can be managed by surgery and/or radiotherapy, a relevant number of patients...
0
1
9
Chimeric antigen receptor (CAR) T cell-based targeting of #CD317 as a novel immunotherapeutic strategy against #glioblastoma. https://t.co/GcUXkeXQtP
#btsm @NeuroOnc
academic.oup.com
AbstractBackground. Chimeric antigen receptor (CAR) T cell therapy has proven to be successful against hematological malignancies. However, exploiting CAR
0
2
10